NSE:INDRAMEDCO Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	14,515	13,564	12,447	10,987	8,882	6,134
Revenue Growth (YoY)	8.53%	8.97%	13.29%	23.70%	44.80%	-26.17%
Cost of Revenue	5,765	5,278	5,040	4,630	4,059	3,257
Gross Profit	8,750	8,286	7,407	6,357	4,823	2,877
Selling, General & Admin	876.5	876.5	1,066	894.6	552.1	284.5
Other Operating Expenses	5,191	4,961	4,396	3,947	3,070	2,182
Operating Expenses	6,499	6,281	5,863	5,234	3,972	2,800
Operating Income	2,251	2,005	1,545	1,123	851.3	76.6
Interest Expense	-27.8	-30.3	-10.6	-4.6	-6.1	-
Interest & Investment Income	226.5	226.5	168.9	100.3	31.2	6.8
Other Non Operating Income (Expenses)	18.8	-32.4	-30	-38.2	-28	-33.4
EBT Excluding Unusual Items	2,468	2,168	1,673	1,181	848.4	50
Gain (Loss) on Sale of Assets	-5.2	-5.2	-11.7	-8.7	-57.7	-7.1
Pretax Income	2,463	2,163	1,661	1,172	790.7	42.9
Income Tax Expense	633.5	553.3	421.5	310.3	204.5	19.6
Net Income	1,829	1,610	1,240	861.5	586.2	23.3
Net Income to Common	1,829	1,610	1,240	861.5	586.2	23.3
Net Income Growth	21.02%	29.87%	43.89%	46.96%	2415.88%	-94.66%
Shares Outstanding (Basic)	92	92	92	92	92	92
Shares Outstanding (Diluted)	92	92	92	92	92	92
EPS (Basic)	19.95	17.56	13.52	9.40	6.39	0.25
EPS (Diluted)	19.95	17.56	13.52	9.40	6.39	0.25
EPS Growth	20.98%	29.88%	43.87%	47.07%	2456.00%	-94.75%
Free Cash Flow	-	1,204	1,308	998.9	648.2	58.5
Free Cash Flow Per Share	-	13.14	14.26	10.90	7.07	0.64
Dividend Per Share	-	4.500	4.500	3.000	2.500	-
Dividend Growth	-	-	50.00%	20.00%	-	-
Gross Margin	60.28%	61.09%	59.51%	57.86%	54.30%	46.90%
Operating Margin	15.50%	14.78%	12.41%	10.22%	9.59%	1.25%
Profit Margin	12.60%	11.87%	9.96%	7.84%	6.60%	0.38%
Free Cash Flow Margin	-	8.88%	10.51%	9.09%	7.30%	0.95%
EBITDA	2,680	2,405	1,907	1,477	1,160	371
EBITDA Margin	18.46%	17.73%	15.32%	13.44%	13.06%	6.05%
D&A For EBITDA	429.13	400.7	362.8	354	308.3	294.4
EBIT	2,251	2,005	1,545	1,123	851.3	76.6
EBIT Margin	15.50%	14.78%	12.41%	10.22%	9.59%	1.25%
Effective Tax Rate	25.72%	25.58%	25.37%	26.48%	25.86%	45.69%
Revenue as Reported	14,792	13,790	12,616	11,087	8,913	6,141

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.